Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any hereditary spastic paraplegia in which the cause of the disease is an autosomal recessive mutation in the PCYT2 gene.
Features include always present findings: Brain shrinkage (cerebral atrophy), Delayed ability to walk, Loss of previously acquired skills (developmental regression), and Babinski sign and others; and very common findings: Bilateral tonic-clonic seizure with generalized onset. 14 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Brain shrinkage (cerebral atrophy), Delayed speech and language development, Loss of previously acquired skills (developmental regression) |
PCYT2 function has not been fully characterized.
Spastic paraplegia 82, autosomal recessive is associated with mutations in the PCYT2 gene on chromosome 17.
Genetic testing for PCYT2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spastic paraplegia 82, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 9 always present features, 1 very common feature, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spastic paraplegia 82, autosomal recessive.
3 publications have been identified in PubMed for spastic paraplegia 82, autosomal recessive. Research spans Diagnostic / Biomarker (33%), Case Report / Case Series (33%), and Epidemiology / Natural History (33%).
Kessler C (2026). [PMID: 40961460](https://pubmed.ncbi.nlm.nih.gov/40961460/). *Amyotrophic lateral sclerosis & frontotemporal degeneration*. [Epidemiology / Natural History]
Safka Brozkova D (2026). [PMID: 41749354](https://pubmed.ncbi.nlm.nih.gov/41749354/). *Human genomics*. [Diagnostic / Biomarker]
Dash A (2025). [PMID: 39884309](https://pubmed.ncbi.nlm.nih.gov/39884309/). *Journal of movement disorders*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 9:50 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Muscles | 2 | Brain shrinkage (cerebral atrophy), Damage to the optic nerve (optic atrophy) |
Eyes | 2 | Nystagmus, Damage to the optic nerve (optic atrophy) |
Age of onset: childhood, infancy.